- Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial2010 | 3. lékařská fakulta
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention2017 | Publikace bez příslušnosti k fakultě
- Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial2019 | Publikace bez příslušnosti k fakultě
- Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines: Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial2009 | 3. lékařská fakulta
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes2012 | Publikace bez příslušnosti k fakultě
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial2012 | Publikace bez příslušnosti k fakultě
- How would I treat?2015 | 3. lékařská fakulta
- Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction2019 | 3. lékařská fakulta
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | 3. lékařská fakulta
- Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention2012 | Lékařská fakulta v Plzni
- Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes2013 | 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Chapter 47: Percutaneous coronary interventions in patiens with acute coronary syndromes2015 | 3. lékařská fakulta
- Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study2015 | 3. lékařská fakulta
- Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial2009 | 3. lékařská fakulta
- Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel2015 | 3. lékařská fakulta